Robert A. Hauser, MD

Director, Parkinson's & Movement Disorder Center
University of South Florida, Tampa

Poster(s):

• (87) Efficacy and safety of tavapadon, an orally administered, once-daily, selective D1/D5 dopamine agonist, adjunctive to levodopa for treatment of Parkinson’s disease with motor fluctuations
  Wednesday, October 29, 2025